Kiely Wealth Advisory Group »

Peregrine Pharmaceuticals shares owned by Kiely Wealth Advisory Group

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Kiely Wealth Advisory Group from 13F filings

Historical chart of Kiely Wealth Advisory Group investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Kiely Wealth Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Kiely Wealth Advisory Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $355 29 12.24
2024-06-30 $304 29 10.52
2024-03-31 $219 29 7.59
2023-12-31 $205 29 7.10

More positions owned by Kiely Wealth Advisory Group

Wisdomtree Floating Ratetreasry Etf Etf (USFR)
Invsc S P 500 Equal Weight Etf Etf (RSP)
Vanguard Mid Cap Etf Etf (VO)
Ishares Treasury Floatngrate Bd Etf Etf (TFLO)
Vanguard S&p 500 Etf Etf (VOO)
Ishares High Yield Corporat Bond Etf Etf (SHYG)
Boston Scientific Corp Equity (BSV)
Vanguard Russell 2000 Etf Etf (VTWO)
Microsoft Corp Equity (MSFT)
Vanguard S&p 500 Value Etf Etf (VOOV)
Invsc Qqq Trust Srs 1 Etf Etf (QQQ)
Amazon.com Equity (AMZN)
Berkshire Hathaway Class B Equity (BRK.B)
Vanguard Mid Cap Value Etf Etf (VOE)
Taiwan Semiconductor M Fsponsored Adr 1 Adr Reps 5 Ord Equity (TSM)

View all positions for Kiely Wealth Advisory Group

Top funds holding Peregrine Pharmaceuticals

BlackRock
BlackRock
Point72 Asset Management
Vanguard Group
AltraVue Capital
State Street Corporation
Royal Bank of Canada
First Light Asset Management
Palisade Capital Management
Snyder Capital Management
Portolan Capital Management
Geode Capital Management
Emerald Advisers
Citadel Advisors
Harbor Capital Advisors

View all funds holding Peregrine Pharmaceuticals